| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2011 | EP2275443A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 01/19/2011 | EP2275442A1 Detection and vizualization of the cell cycle in living cells |
| 01/19/2011 | EP2275441A1 High affinity HIV T cell receptors |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275435A2 Streptococcus agalactiae antigens I + II |
| 01/19/2011 | EP2275431A2 Enhanced fractionation of phosphorylated and nonphosphorylated biomolecules by apatite chromotography |
| 01/19/2011 | EP2275132A2 Multivalent PCV2 immunogenic compositions and methods of producing them |
| 01/19/2011 | EP2275118A2 Pancreas-specific proteins |
| 01/19/2011 | EP2275115A2 Inhibition of stress-induced ligand-dependent EGFR activation |
| 01/19/2011 | EP2274973A1 Agrobacterium-mediated method for producing transformed plant |
| 01/19/2011 | EP2274448A2 Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
| 01/19/2011 | EP2274443A2 Capture agents and related methods and systems for detecting and/or sorting targets |
| 01/19/2011 | EP2274432A1 A method for the production of a human protein in a plant, in particular a human recombinant lysosomal enzyme in a cereal endosperm |
| 01/19/2011 | EP2274431A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/19/2011 | EP2274430A2 Neural regenerating cells with alterations in dna methylation |
| 01/19/2011 | EP2274429A1 Multizymes |
| 01/19/2011 | EP2274428A1 Isolated peptides having phospholipase inhibitory activity |
| 01/19/2011 | EP2274427A2 Tat dna sequences, gene constructs, vaccine and processes thereof |
| 01/19/2011 | EP2274426A1 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
| 01/19/2011 | EP2274425A2 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 01/19/2011 | EP2274424A2 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator |
| 01/19/2011 | EP2274423A2 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity |
| 01/19/2011 | EP2274422A1 Expression vector |
| 01/19/2011 | EP2274421A1 Cis-acting diversification activator and method for selective diversification of nucleic acids |
| 01/19/2011 | EP2274417A2 Cellular production of glucaric acid |
| 01/19/2011 | EP2274416A2 Commensal bacteria as signal mediators within a mammalian host |
| 01/19/2011 | EP2274326A1 Suppressor of the endogenous interferon- gamma |
| 01/19/2011 | EP2274325A1 Human g-csf analogs and methods of making and using thereof |
| 01/19/2011 | EP2274324A1 Substances and compositions for enhancing dna repair and methods of use |
| 01/19/2011 | EP2274322A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same |
| 01/19/2011 | EP2273998A2 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents |
| 01/19/2011 | EP2083074B1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
| 01/19/2011 | EP1984524B8 Plant chimeric binding polypeptides for universal molecular recognition |
| 01/19/2011 | EP1981978B1 Affinity polypeptide for purification of recombinant proteins |
| 01/19/2011 | EP1945043B1 Microorganism and process for the preparation of l-methionine |
| 01/19/2011 | EP1894214B1 Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use |
| 01/19/2011 | EP1781795B1 Methods of protecting plants from pathogenic fungi |
| 01/19/2011 | EP1730275B1 Lactobacillus fermentum n-desoxyribosyl transferases and the use thereof for enzymatic synthesis of 2', 3' -didesoxynucleosides and 2',3'-didehydro-2', 3'-didesoxynucleosides |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1644501B1 Ssx-2 peptides presented by hla class ii molucules |
| 01/19/2011 | EP1600507B1 Mutant SREBP-1c promoters and use thereof |
| 01/19/2011 | EP1590663B1 Immunocompromised rodents as dual color tumor models |
| 01/19/2011 | EP1492874B1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
| 01/19/2011 | EP1423419B1 Hybrid and tandem expression of neisserial proteins |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 01/19/2011 | EP1363997B1 Concentration and lysis of adenovirus-infected cells in a single unit operation |
| 01/19/2011 | EP1362125B8 METHOD FOR IDENTIFYING of BIOLOGICALLY ACTIVE STRUCTURES OF MICROBIAL PATHOGENS |
| 01/19/2011 | EP1357832B1 Techniques for deriving tissue structure from multiple projection dual-energy x-ray absorptiometry |
| 01/19/2011 | EP1326964B1 THERMOSTABLE POLYMERASE BASED ON i THERMOCOCCUS PACIFICUS /i |
| 01/19/2011 | EP1325019B1 Antisense modulation of clusterin expression |
| 01/19/2011 | EP1252300B1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 01/19/2011 | EP1224299B1 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | EP1132475B1 Novel serine protease bssp2 |
| 01/19/2011 | EP1027418B2 Cleaning compositions containing multiply-substituted protease variants |
| 01/19/2011 | CN1834231B Method and equipment for cultivating anaerobic ammonium-oxidizing bacteria |
| 01/19/2011 | CN1814302B Method for selectively increasing tumor cell sensitivity to ionic radiation |
| 01/19/2011 | CN1809633B Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/19/2011 | CN1468304B Method of producing functional protein domains |
| 01/19/2011 | CN101952460A Method of preparing fecal sample, solution for preparing fecal sample and feces collection kit |
| 01/19/2011 | CN101952447A Regeneration and mass propagation of jatropha curcas through somatic embryogenesis |
| 01/19/2011 | CN101952446A Protein expression systems |
| 01/19/2011 | CN101952445A Trichome specific promoters |
| 01/19/2011 | CN101952444A Plants with increased yield (KO NUE) |
| 01/19/2011 | CN101952443A Drought tolerant plants and related constructs and methods involving genes encoding miR827 |
| 01/19/2011 | CN101952442A Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 01/19/2011 | CN101952441A Plants having enhanced yield-related traits and a method for making the same |
| 01/19/2011 | CN101952440A Expression vector suitable for expression of a coding sequence for gene therapy |
| 01/19/2011 | CN101952439A Expression system used for the antibiotic-free production of polypeptides |
| 01/19/2011 | CN101952438A Production of soluble recombinant protein by PI value control of N-terminal |
| 01/19/2011 | CN101952437A Xylanases, nucleic acids encoding them and methods for making and using them |
| 01/19/2011 | CN101952436A Baculovirus-based vaccines |
| 01/19/2011 | CN101952435A Promoter, promoter control elements, and combinations, and use thereof |
| 01/19/2011 | CN101952434A Means for delivery of nucleic acids active for gene silencing using synthetic polymers |
| 01/19/2011 | CN101952433A PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 01/19/2011 | CN101952432A Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 01/19/2011 | CN101952431A Transformed plant with promoted growth |
| 01/19/2011 | CN101952430A Enhanced ethanol and butanol producing microorganisms and method for preparing ethanol and butanol using the same |
| 01/19/2011 | CN101952429A STAT3 epitope peptides |
| 01/19/2011 | CN101952428A Mutant pyrrolysyl-tRNA synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 01/19/2011 | CN101952427A Novel constructs for expression of influenza virus |
| 01/19/2011 | CN101952426A Anti-BST2 antibody |
| 01/19/2011 | CN101952425A Glucose-induced inactivation/degradation resistant transporter gene and use thereof |
| 01/19/2011 | CN101952424A New proteins for use in human and animal staphylococcus infections |
| 01/19/2011 | CN101952421A Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 01/19/2011 | CN101952420A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/19/2011 | CN101952417A Enzyme involved in synthesis of equol |
| 01/19/2011 | CN101952413A Method for stonewashing fabrics using cellulase |
| 01/19/2011 | CN101952321A Recombinant RSV antigens |
| 01/19/2011 | CN101952320A Material with immunogenicity |
| 01/19/2011 | CN101952318A Anti-NR10 antibody, and use thereof |
| 01/19/2011 | CN101952311A G immunoglobulin used against anthrax toxins |
| 01/19/2011 | CN101952305A Plants with increased yield and/or increased tolerance to environmental stress (IV-BM) |
| 01/19/2011 | CN101952300A Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria |
| 01/19/2011 | CN101951953A Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient |
| 01/19/2011 | CN101951755A Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae |
| 01/19/2011 | CN101949937A Time-resolved fluorescence (TRF) immunized detection kit of ovarian cancer tumor marker HE4 |
| 01/19/2011 | CN101949936A Colloidal gold test strip for detecting antibodies against akabane virus and preparation method thereof |
| 01/19/2011 | CN101949934A Early infection detection kit of monoclonal antibody-mediated pig pleuropneumoniae |